Vaxcyte (PCVX) Q4 2023 Earnings Report

483 Followers

PCVX Q4 2023 EPS Results

Actual EPS-$1.83

Consensus EPS-$1.05

Beat/MissMissed by -$0.78

One Year Ago EPS-$1.03

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2023

Date02/27/2024

TimeAfter Close

Conference CallTuesday, February 27, 2024

PCVX Upcoming Earnings

Vaxcyte's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

PCVX Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	-2.12 / -	-1.56	―
Aug 05, 2026	2026 (Q2)	-2.06 / -1.97	-1.22	-61.48% (-0.75)
May 06, 2026	2026 (Q1)	-1.78 / -2.30	-1.04	-121.15% (-1.26)
Feb 24, 2026	2025 (Q4)	-1.53 / -1.81	-1.02	-77.45% (-0.79)
Nov 04, 2025	2025 (Q3)	-1.24 / -1.56	-0.83	-87.95% (-0.73)
Aug 06, 2025	2025 (Q2)	-1.16 / -1.22	-1.1	-10.91% (-0.12)
May 07, 2025	2025 (Q1)	-1.06 / -1.04	-0.85	-22.35% (-0.19)
Feb 25, 2025	2024 (Q4)	-1.11 / -1.02	-1.83	44.26% (+0.81)
Nov 05, 2024	2024 (Q3)	-1.10 / -0.83	-0.91	8.79% (+0.08)
Aug 06, 2024	2024 (Q2)	-0.98 / -1.10	-0.7	-57.14% (-0.40)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed